Table of Content

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Australia Lung Cancer Screening Market – by Technology
1.3.2 Australia Lung Cancer Screening Market – by Cancer Type
1.3.3 Australia Lung Cancer Screening Market – by Age Group
1.3.4 Australia Lung Cancer Screening Market – by End User

2. Australia Lung Cancer Screening Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Australia Lung Cancer Screening Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert’s Opinion
4.4 Demographics of Smoking, by Key States
4.5 Demographics of Smoking, by Income Bracket
4.6 Epidemiology of Lung Cancer in Australia
4.7 Patterns of Smoking in Australia
4.8 Trends Of Smoking in Australia
4.9 Regional Comparative Analysis of Smoking (Asian and European)

5. Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Lung Cancer
5.1.2 Rising Government Support
5.2 Market Restraints
5.2.1 Uncertainties Related to Lung Cancer Screening Trial with LDCT
5.3 Market Opportunities
5.3.1 Structured Lung Cancer Screening Program
5.4 Future Trends
5.4.1 Mobile Lung Cancer Screening Truck
5.5 Impact Analysis

6. Lung Cancer Screening Market – Australia Analysis
6.1 Australia Lung Cancer Screening Market Revenue Forecast and Analysis

7. Australia Lung Cancer Screening Market Analysis – by Cancer Type
7.1 Overview
7.2 Australia Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Thousand)
7.3 Non–Small Cell Lung Cancer (NSCLC)
7.3.1 Overview
7.3.2 Non–small cell lung cancer (NSCLC): Australia Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Thousand)
7.4 Small Cell Lung Cancer
7.4.1 Overview
7.4.2 Small Cell Lung Cancer: Australia Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Thousand)

8. Australia Lung Cancer Screening Market Analysis – by Technology
8.1 Overview
8.2 Australia Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Thousand)
8.3 Low-Dose Computed Tomography (LDCT)
8.3.1 Overview
8.3.2 Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Thousand)
8.4 Chest X-ray
8.4.1 Overview
8.4.2 Chest X-ray: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Thousand)
8.5 Liquid Biopsy
8.5.1 Overview
8.5.2 Liquid Biopsy: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Thousand)
8.6 Others
8.6.1 Overview
8.6.2 Others: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Thousand)

9. Australia Lung Cancer Screening Market Analysis – by Age Group
9.1 Overview
9.2 Australia Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Thousand)
9.3 & Older
9.3.1 Overview
9.3.2 & Older: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Thousand)
9.4 Below 50
9.4.1 Overview
9.4.2 Below 50: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Thousand)

10. Australia Lung Cancer Screening Market Analysis – by End User
10.1 Overview
10.2 Australia Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Thousand)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Thousand)
10.4 Diagnostic Centers
10.4.1 Overview
10.4.2 Diagnostic Centers: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Thousand)
10.5 Others
10.5.1 Overview
10.5.2 Others: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Thousand)

11. Australia Lung Cancer Screening Market: Impact Assessment of COVID-19 Pandemic
11.1 Impact Analysis of COVID-19 Pandemic on Australia Lung Cancer Screening Market

12. Australia Lung Cancer Screening Market–Industry Landscape
12.1 Recent Growth Strategies
12.1.1 Overview

13. Company Profiles
13.1 Intelerad Medical Systems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Nuance Communications Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE HealthCare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Medtronic
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Canon Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Koninklijke Philips NV
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Siemens AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 CVS Health
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 bioAffinity Technologies, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 LungLife AI, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Lung Screen Australia Pty Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms



List of Figures

LIST OF FIGURES

Figure 1. Australia Lung Cancer Screening Market Segmentation
Figure 2. Australia Lung Cancer Screening Market Overview
Figure 3. Non-Small Cell Lung Cancer Segment Held Largest Share Under Cancer Type Segment in Australia Lung Cancer Screening Market
Figure 4. Experts’ Opinion
Figure 5. Australia Lung Cancer Screening Market: Impact Analysis of Drivers and Restraints
Figure 6. Australia Lung Cancer Screening Market – Revenue Forecast and Analysis – 2020- 2030
Figure 7. Market Positioning of Key Players in Australia Lung Cancer Screening Market
Figure 8. Australia Lung Cancer Screening Market, by Cancer Type, 2022 & 2030 (%)
Figure 9. Non–Small Cell Lung Cancer (NSCLC): Australia Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 10. Small Cell Lung Cancer: Australia Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 11. Australia Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 12. Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Thousand)
Figure 13. Chest X-ray: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Thousand)
Figure 14. Liquid Biopsy: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Thousand)
Figure 15. Others: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Thousand)
Figure 16. Australia Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 17. & Older: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 18. Below 50: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 19. Australia Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 20. Hospitals: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 21. Diagnostic Centers: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 22. Others: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 23. Pre and Post COVID-19 Pandemic Impact in the Australia Market

List of Tables

LIST OF TABLES

Table 1. Australia Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 2. Australia Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Thousand)
Table 3. Australia Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Thousand)
Table 4. Australia Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Thousand)
Table 5. Recent Growth Strategies in the Australia Lung Cancer Screening Market
Table 6. Glossary of Terms